BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 21040709)

  • 1. Ghrelin inhibits proliferation and increases T-type Ca2+ channel expression in PC-3 human prostate carcinoma cells.
    Díaz-Lezama N; Hernández-Elvira M; Sandoval A; Monroy A; Felix R; Monjaraz E
    Biochem Biophys Res Commun; 2010 Dec; 403(1):24-9. PubMed ID: 21040709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenomedullin (AM) and AM receptor type 2 expression is up-regulated in prostate carcinomas (PC), and AM stimulates in vitro growth of a PC-derived cell line by enhancing proliferation and decreasing apoptosis rates.
    Mazzocchi G; Malendowicz LK; Ziolkowska A; Spinazzi R; Rebuffat P; Aragona F; Ferrazzi E; Parnigotto PP; Nussdorfer GG
    Int J Oncol; 2004 Dec; 25(6):1781-7. PubMed ID: 15547717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-type calcium channels and tumor proliferation.
    Panner A; Wurster RD
    Cell Calcium; 2006 Aug; 40(2):253-9. PubMed ID: 16765439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-type voltage-activated calcium channel Cav3.1, but not Cav3.2, is involved in the inhibition of proliferation and apoptosis in MCF-7 human breast cancer cells.
    Ohkubo T; Yamazaki J
    Int J Oncol; 2012 Jul; 41(1):267-75. PubMed ID: 22469755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ghrelin and a novel preproghrelin isoform are highly expressed in prostate cancer and ghrelin activates mitogen-activated protein kinase in prostate cancer.
    Yeh AH; Jeffery PL; Duncan RP; Herington AC; Chopin LK
    Clin Cancer Res; 2005 Dec; 11(23):8295-303. PubMed ID: 16322288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Induction of apoptosis by mifepristone in androgen-independent prostate cancer cell lines in vitro].
    Zhang H; Lü JJ; Gao QZ; Zhang J
    Zhonghua Wai Ke Za Zhi; 2006 Mar; 44(6):382-5. PubMed ID: 16638347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-Chloroethyl-3-sarcosinamide-1-nitrosourea (SarCNU) inhibits prostate carcinoma cell growth via p53-dependent and p53-independent pathways.
    Huynh H; Nguyen TH; Panasci L; Do P
    Cancer; 2004 Dec; 101(12):2881-91. PubMed ID: 15529313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of cell cycle arrest and apoptosis in human prostate carcinoma cells by a recombinant adenovirus expressing p27(Kip1).
    Katner AL; Hoang QB; Gootam P; Jaruga E; Ma Q; Gnarra J; Rayford W
    Prostate; 2002 Sep; 53(1):77-87. PubMed ID: 12210483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of T-type calcium channel expression by sodium butyrate in prostate cancer cells.
    Weaver EM; Zamora FJ; Puplampu-Dove YA; Kiessu E; Hearne JL; Martin-Caraballo M
    Eur J Pharmacol; 2015 Feb; 749():20-31. PubMed ID: 25557765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nkx3.1 and p27(KIP1) cooperate in proliferation inhibition and apoptosis induction in human androgen-independent prostate cancer cells.
    Wang P; Ma Q; Luo J; Liu B; Tan F; Zhang Z; Chen Z
    Cancer Invest; 2009 May; 27(4):369-75. PubMed ID: 19266349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cathepsin E enhances anticancer activity of doxorubicin on human prostate cancer cells showing resistance to TRAIL-mediated apoptosis.
    Yasukochi A; Kawakubo T; Nakamura S; Yamamoto K
    Biol Chem; 2010 Aug; 391(8):947-58. PubMed ID: 20482316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRPV6 channel controls prostate cancer cell proliferation via Ca(2+)/NFAT-dependent pathways.
    Lehen'kyi V; Flourakis M; Skryma R; Prevarskaya N
    Oncogene; 2007 Nov; 26(52):7380-5. PubMed ID: 17533368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Equiguard suppresses androgen-dependent LNCaP prostate cancer cell proliferation by targeting cell cycle control via down regulation of the retinoblastoma protein Rb and induction of apoptosis via the release of cytochrome c.
    Lu X; Hsieh TC; Wu JM
    Int J Oncol; 2004 Dec; 25(6):1801-7. PubMed ID: 15547720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bcl-2-dependent modulation of swelling-activated Cl- current and ClC-3 expression in human prostate cancer epithelial cells.
    Lemonnier L; Shuba Y; Crepin A; Roudbaraki M; Slomianny C; Mauroy B; Nilius B; Prevarskaya N; Skryma R
    Cancer Res; 2004 Jul; 64(14):4841-8. PubMed ID: 15256454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. INSL3 in the benign hyperplastic and neoplastic human prostate gland.
    Klonisch T; Müller-Huesmann H; Riedel M; Kehlen A; Bialek J; Radestock Y; Holzhausen HJ; Steger K; Ludwig M; Weidner W; Hoang-Vu C; Hombach-Klonisch S
    Int J Oncol; 2005 Aug; 27(2):307-15. PubMed ID: 16010410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of the type I IGF receptor expression in human prostate cancer cells inhibits proliferation and invasion, up-regulates IGF binding protein-3, and suppresses MMP-2 expression.
    Grzmil M; Hemmerlein B; Thelen P; Schweyer S; Burfeind P
    J Pathol; 2004 Jan; 202(1):50-9. PubMed ID: 14694521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-type Ca2+ channel blockers suppress the growth of human cancer cells.
    Heo JH; Seo HN; Choe YJ; Kim S; Oh CR; Kim YD; Rhim H; Choo DJ; Kim J; Lee JY
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3899-901. PubMed ID: 18585035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abrogation of heat-shock protein (HSP)70 expression induced cell growth inhibition and apoptosis in human androgen-independent prostate cancer cell line PC-3m.
    Zhao ZG; Ma QZ; Xu CX
    Asian J Androl; 2004 Dec; 6(4):319-24. PubMed ID: 15546023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GDF-9 promotes the growth of prostate cancer cells by protecting them from apoptosis.
    Bokobza SM; Ye L; Kynaston HG; Jiang WG
    J Cell Physiol; 2010 Nov; 225(2):529-36. PubMed ID: 20458753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of cysteinyl LT1 receptor in prostate cancer and CysLT1R antagonist inhibits prostate cancer cell growth through apoptosis.
    Matsuyama M; Hayama T; Funao K; Kawahito Y; Sano H; Takemoto Y; Nakatani T; Yoshimura R
    Oncol Rep; 2007 Jul; 18(1):99-104. PubMed ID: 17549353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.